251 related articles for article (PubMed ID: 8805677)
1. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
2. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
3. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
4. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
5. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
Notkins AL; Zhang B; Matsumoto Y; Lan MS
J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
[TBL] [Abstract][Full Text] [Related]
6. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined.
Xie H; Zhang B; Matsumoto Y; Li Q; Notkins AL; Lan MS
J Immunol; 1997 Oct; 159(7):3662-7. PubMed ID: 9317167
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterisation of a human monoclonal autoantibody to the islet cell autoantigen IA-2.
Ananieva-Jordanova R; Evans M; Nakamatsu T; Premawardhana LD; Sanders J; Powell M; Chen S; McGrath V; Belton C; Arnold C; Baker S; Betterle C; Zanchetta R; Smith BR; Furmaniak J
J Autoimmun; 2005 Jun; 24(4):337-45. PubMed ID: 15869863
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody 76F distinguishes IA-2 from IA-2beta and overlaps an autoantibody epitope.
Piquer S; Valera L; Lampasona V; Jardin-Watelet B; Roche S; Granier C; Roquet F; Christie MR; Giordano T; Malosio ML; Bonifacio E; Laune D
J Autoimmun; 2006 May; 26(3):215-22. PubMed ID: 16503116
[TBL] [Abstract][Full Text] [Related]
11. Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes.
Kawasaki E; Sera Y; Fujita N; Yamauchi M; Ozaki M; Abe T; Yamakawa K; Uotani S; Takino H; Yamasaki H; Yamaguchi Y; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 2001 Dec; 17(4):323-31. PubMed ID: 11771957
[TBL] [Abstract][Full Text] [Related]
12. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).
Payton MA; Hawkes CJ; Christie MR
J Clin Invest; 1995 Sep; 96(3):1506-11. PubMed ID: 7657822
[TBL] [Abstract][Full Text] [Related]
14. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes.
Kawasaki E; Hutton JC; Eisenbarth GS
Biochem Biophys Res Commun; 1996 Oct; 227(2):440-7. PubMed ID: 8878534
[TBL] [Abstract][Full Text] [Related]
16. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
17. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen.
Kolm-Litty V; Berlo S; Bonifacio E; Bearzatto M; Engel AM; Christie M; Ziegler AG; Wild T; Endl J
J Immunol; 2000 Oct; 165(8):4676-84. PubMed ID: 11035111
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
[TBL] [Abstract][Full Text] [Related]
19. Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
Morgenthaler NG; Löbner K; Morgenthaler UY; Christie MR; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Sep; 30(9):559-64. PubMed ID: 9808324
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]